Maesaka K, Sakamori R, Yamada R, Doi A, et al. Pretreatment with antibiotics is associated with reduced therapeutic response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma. PLoS One 2023;18:e0281459.
PMID: 36749777